Previous Article | Next Article ![]()
Journal of Bacteriology, March 2000, p. 1321-1327, Vol. 182, No. 5
Abteilung für
Transfusionsmedizin1 and Medizinische
Universitätsklinik und Poliklinik,4
Universitätsklinikum Tübingen, D-72076 Tübingen, and
Abteilung Neonatologie, Kinderklinik der Universität
Bonn, Bonn,5 Germany; Institute of
Epidemiology and Microbiology, Chinese Academy of Preventive Medicine,
Changping, Beijing 102206, Peoples Republic of
China2; and Department of Microbiology
and Immunology, Chandler Medical Center, University of Kentucky,
Lexington, Kentucky 405363
Received 1 September 1999/Accepted 19 November 1999
Bacterial phospholipases are regarded as a major virulence factor
in infection. In bacteria associated with pneumonia, destruction of
lung surfactant and host cell membranes by bacterial phospholipases secreted during infection is thought to contribute to the disease. Phospholipase C (PLC) activity has been described in several
Legionella species (W. B. Baine, J. Gen.
Microbiol. 134:489-498, 1988; W. B. Baine, J. Gen.
Microbiol. 131:1383-1391, 1985). By using detection methods such as
thin-layer chromatography and mass spectrometry, PLC activity could not
be detected in several strains of Legionella pneumophila.
Instead, phospholipid degradation was identified to be caused by a
novel PLA activity. We could demonstrate that PLA secretion starts at
the mid-exponential-growth phase when bacteria were grown in liquid
culture. Several Legionella species secreted different
amounts of PLA. Legionella PLA may act as a powerful agent
in the mediation of pathogenicity due to destruction of lung surfactant
and epithelial cells.
Destruction of phospholipids (PLs)
by bacterial phospholipases and the subsequent change of membrane
constituents which can lead to cell damage is regarded to be a major
virulence mechanism in infection. More than a decade ago, Baine
evaluated several species of Legionella for cytolytic
activity and elaboration of phospholipase C (PLC) to examine one
possible mechanism of damage to leucocytes and tissue cells in
legionellosis. PLC activity was detected by release of
p-nitrophenol (p-NP) from
p-nitrophenylphosphorylcholine (p-NPPC) and by
release of tritiated phosphorylcholine (3H-PrC) from
L- In 1988, Baine purified PLC from L. pneumophila sg 5 Dallas
1E from the supernatant of a liquid culture in buffered yeast extract
(BYE) broth by ion-exchange chromatography, followed by manganous
chloride and ammonium sulfate precipitation. Enzyme activity was
assayed by hydrolysis of p-NPPC and was confirmed by release
of radioactivity from 3H-PC. After sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), the purified
preparation yielded a single 50- to 54-kDa band upon Coomassie blue
staining. In contrast to hemolysis induced by bacteria grown on ABYE
blood agar, the purified enzyme did not exhibit hemolytic activity
(2). Since alveolar hyaline membrane formation has been
reported in legionellosis (39), Baine speculated that the
release of PLC by legionellae may cause damage of lung surfactant by
hydrolysis of dipalmitoylphosphatidylcholine. Moreover, since PLC
catalyzes the hydrolysis of phospholipid phosphodiesters and releases
phosphomonoester and 1,2-diacylglycerol (1,2-DG), the latter could play
an important role as a second messenger in signal transduction
(4). To show destruction of lung surfactant by
Legionella-PLC (A. Flieger et al., submitted for
publication) and to characterize the contribution of this enzyme to
intracellular survival of bacteria within monocytic cells
(25), we tried to reproduce the previous purification
protocol. By using detection methods such as thin-layer chromatography
(TLC) and mass spectrometry (MS), which are more appropriate for
characterization of phospholipases that are produced in combination
with other enzymes (11a), PLC activity could not be detected
in several strains of L. pneumophila. As we show here,
generation of p-NP from p-NPPC was caused by Legionella phosphatase, and release of radioactivity from
3H-PC was caused by release of tritiated
glycerophosphorylcholine (GPC) instead of 3H-PrC. GPC was
formed by a newly described PLA activity which could be detected in
several Legionella species.
Reagents.
BYE supplement for Legionella BYE broth
was obtained from Oxoid (Wessel, Germany). Yeast extract for
Legionella BYE broth, ingredients for BCYE
0021-9193/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Novel Phospholipase A Activity Secreted by
Legionella Species
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results and Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results and Discussion
References
-dipalmitoyl-[choline-methyl-3H]phosphatidylcholine
(3H-PC). Legionella pneumophila, L. bozemanii, L. micdadei, L. dumoffii, L. gormanii, L. longbeachae, and L. jordanis all lysed dog red blood cells, which have a high ratio of
membrane phosphatidylcholine (PC) to sphingomyelin. The same strains
hydrolyzed various amounts of p-NPPC; L. bozemanii exhibited the greatest activity. In decreasing quantity, L. pneumophila, L. dumoffii,
L. jordanis, L. bozemanii, and L. longbeachae, but not L. micdadei, released a
radioactive water-soluble product from 3H-PC which was
assumed to be 3H-PrC. Baine concluded that five of the six
Legionella species under investigation possessed PLC
activity (3).
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results and Discussion
References
agar, sodium
azide, Tris-HCl, methanol, n-hexane, diethyl ether, glacial
acetic acid, manganous chloride, sodium potassium tartrate, silica gel
TLC plates, and chloroform were purchased from Merck (Darmstadt,
Germany). Alveofact (consisting of 3% cholesterol and cholesterol
ester, 0.5% free fatty acids [FFA], 4% triglycerides, 90% PLs
[72% PC, 10% phosphatidylglycerol, 8% other PLs], and 1% protein)
was kindly provided by Boehringer-Ingelheim-Pharma-KG (Biberach, Germany).
-ketoglutarate
(K-2000), calcium chloride, ferric chloride (F-2877),
L-cysteine-HCl (C-1276), ACES
N-(2-acetamido)-2-aminoethanesulfonic acid; A-9758),
1,2-dipalmitoylglycerol (D-9135), palmitic acid (P-0500), and
PC-specific PLC (EC 3.1.4.3) from Clostridium perfringens
(P-7633) were purchased from Sigma-Aldrich (Munich, Germany). Source
30Q,
L-
-dipalmitoyl-[choline-methyl]-3H]phosphatidylcholine
(specific activity, 81 Ci/mmol), 12.5% homogenous SDS-PAGE ready gels,
SDS-PAGE buffer strips, and a silver staining kit for proteins were
obtained from Amersham Pharmacia Biotech (Freiburg, Germany).
Low-molecular-weight standards for SDS-PAGE were obtained from Bio-Rad
(Munich, Germany). The scintillation solution Ultima Gold was purchased
from Packard (Dreieich, Germany). Roti-Nanoquant reagent for protein
determination was obtained from Roth (Karlsruhe, Germany).
Bacteria.
The Legionella strains used for
this investigation are listed in Table 1.
|
Preparation of concentrated crude culture supernatant (CCCS) for
detection of PLC activity.
Lp6-c, Lp1-MM6, Lp1-MRC, Lp2-ATCC, and
Lp12-ATCC were grown on BCYE
agar at 37°C in 3% CO2
for 3 days (29). Colonies were suspended in 500 ml of both
BYE broth (2) (0.25% yeast) and low-phosphate BYE broth
(
P broth; ferric pyrophosphate was substituted by ferric chloride
containing 0.4 mM inorganic phosphate) and adjusted to an optical
density at 578 nm (OD578) of 0.2 (Ultrospec 2000; Amersham
Pharmacia Biotech). Bacteria were cultured for 17 h at 37°C in
3% CO2 by vigorous shaking. Culture supernatant was
obtained by centrifugation at 5,000 × g for 30 min.
Then, 3 mM sodium azide was added to prevent contamination. Culture supernatant was concentrated 40-fold by ultrafiltration using a
Acryl-Minitan with polyethersulfone membrane (molecular weight cutoff,
30 kDa) purchased from Millipore (Eschborn, Germany).
Partial purification of the 54-kDa protein.
A total of 6,000 ml of Lp6-c supernatant (
P broth) was concentrated, and CCCS was
directly applied to a 50-ml Source 30Q column preequilibrated in buffer
containing 20 mM Tris-HCl (pH 7.5) for anion-exchange chromatography
(AEC). AEC was carried out at 4°C, and a gradient of 0 to 1 M sodium
chloride in equilibration buffer was used for elution of proteins.
Finally, 10-ml fractions were collected.
Determination of protein. Protein was determined by using Roti-Nanoquant reagent according to the manufacturer's instructions. BSA was used as the standard protein.
SDS-PAGE. Homogenous 12.5% polyacrylamide-SDS-ready gels and SDS buffer strips were used according to the method of Laemmli (20). The molecular mass of the protein bands was determined by means of a low-molecular-mass calibration kit from Bio-Rad. Proteins were visualized by using a silver-staining kit for proteins (Amersham Pharmacia Biotech) according to the manufacturer's instructions.
Hydrolysis of p-NPPC. For detection of p-NPPC hydrolysis by AEC fractions, an assay was carried out using 10 mM p-NPPC, 3 mM NaN3, 20 mM CaCl2, 20 mM MnCl2, 0.5% Triton X-100 (vol/vol), and 20 mM Tris-HCl (pH 7.2). Samples were incubated at 37°C with continuous agitation. The OD was determined after 20 h at 410 nm.
Hydrolysis of phosphomonoesters. For the detection of phosphatase activity, phosphomonoesters were incubated with AEC fractions under the following conditions: 5 mg of PrC-HCl per ml, 2.5 mg of phosphorylethanolamine per ml, 3 mM NaN3, 5 mM CaCl2, 0.5% Triton X-100 (vol/vol), and 20 mM Tris-HCl (pH 7.2). Samples were incubated at 37°C with continuous agitation. Inorganic phosphate (Pi) was estimated after 15 h of incubation according to the method of Eibl and Lands (10).
Hydrolysis of PLs. For detection of PLC activity, PLs were incubated with different samples in a mixture containing 5 mg of Alveofact or 5 mg of PC per ml, 3 mM NaN3, 0.5% Triton X-100, and 20 mM Tris-HCl (pH 7.2) for 16 h at 37°C. Lipids were extracted as described by Bligh and Dyer (5).
TLC. For detection of polar lipids, silica gel plates were developed in tanks containing the following solvent mixture: chloroform-methanol-water in a ratio of 65:25:4 (vol/vol/vol). For apolar lipids, a mixture of n-hexane-diethyl ether-acetic acid in a ratio of 70:30:4 (vol/vol/vol) was used. For visualization, silica plates were then sprayed with copper sulfate phosphoric acid reagent (37).
Hydrolysis of 3H-dipalmitoylphosphatidylcholine.
A total of 250 nCi of
L-
-dipalmitoyl-[choline-methyl-3H]phosphatidylcholine
per ml was dispersed (1 min of vortexing and 1 min of ultrasonication
at a power setting of 5 [B-12 Sonifier; Branson Sonic Power Co.,
Danbury, Conn.], repeated three times) in 14 mM PC in 20 mM Tris-HCl
(pH 7.2) containing 1% Triton X-100 (vol/vol) and 6 mM sodium azide.
The resulting mixture was incubated with the same volume of CCCS of
Lp6-c or with AEC fractions containing the 54-kDa protein, yielding a
final volume of 200 µl. Samples were incubated for 5 h at 37°C
with continuous agitation. Lipids were separated by single extraction
according to the method of Bligh and Dyer (5). For
incubation of 3H-PC with CCCS concentrated BYE broth was
used as a negative control, and for incubation with AEC fractions 20 mM
Tris-HCl (pH 7.2) was used as negative control. An aliquot of the
extracted aqueous phases was transferred to vials containing 10 ml of
scintillation solution for liquid scintillation counting (Beckman LS
1801 Counter; Beckman, Irvine, Calif.). Substrate hydrolysis was
calculated from the difference between counts of samples and negative control.
MS. To analyze water-soluble reaction products, hydrolysis of Alveofact by CCCS of Lp6-c was carried out as described for the hydrolysis of PLs. Lipids were extracted as noted above. Solvents were removed from the water-methanol phase by means of speed vacuum evaporator (Savant, New York, N.Y.) at room temperature. The remaining substances were dissolved in a 1:1 (vol/vol) mixture of water-methanol. After centrifugation (5 min, 2,000 × g), supernatants were introduced into a TSQ700 electrospray ionization (ESI) mass spectrometer (Finnigan, Bremen, Germany) via a syringe pump at a rate of 5 µl/min. The masses of protonated PrC (184.0 ± 0.1) and GPC (258.0 ± 0.1) were detected in addition to the corresponding sodium and potassium adducts. These molecular masses were also observed when authentic substances (Sigma-Aldrich) were analyzed.
Monitoring of PLA formation.
Lp1P-c, Lp1-ATCC, Lp1-CDC,
Lp6-c, Lm-ATCC, Lm-CDC, Ls-ATCC, Ls-CDC, Ld-CDC, Lg-CDC, Lj-CDC,
Ll-CDC, Lo-CDC, Lpa-CDC, and La-CDC were grown on BCYE
agar at
37°C in 3% CO2 for 3 days. Colonies were suspended in 15 ml of BYE broth containing 1% yeast (2) and adjusted to an
OD578 of 0.2 (Ultrospec 2000). Bacteria were cultured in
BYE broth at 37°C in 3% CO2 by vigorous shaking.
Bacterial supernatants were obtained after 12, 16, 20, 24, and 36 h of incubation by centrifugation at 5,000 × g for 10 min. Then, 3 mM sodium azide was added to prevent contamination.
Bacterial supernatants were incubated with Alveofact as mentioned for
the hydrolysis of the PLs. BYE broth without bacteria served as a
negative control. All incubations were performed at 37°C with
continuous agitation. After 24 h, FFA were determined by using the
NEFA-C-Kit from Wako Chemicals (Neuss, Germany) according to the
instructions of the manufacturer. Data were expressed as the difference
between the amount of FFA in samples and in the negative control.
| |
RESULTS AND DISCUSSION |
|---|
|
|
|---|
Phospholipase secreted by legionellae can play an important role in pathogenesis. PC is one of the major constituents of cell membranes as well as of lung surfactant. The lung function can be affected seriously when epithelial cells are damaged (28) or when lung surfactant is hydrolyzed by phospholipases (12). We therefore intended to purify Legionella PLC according to the method of Baine (2), with some modifications.
At first, we investigated several strains of L. pneumophila
for PLC activity as determined by TLC after hydrolysis of PLs. As shown
in Fig. 1A, 1,2-DG could not be detected
in the CCCS of any of the five strains. Instead, FFA were generated.
Since low Pi concentration of culture media is known to
increase PLC secretion by Pseudomonas aeruginosa
(33), we used low-phosphate BYE broth (
P broth) for liquid
culture of several strains of L. pneumophila. However, no
difference in hydrolysis of PC could be found (Fig. 1A). These results
could be explained by two possible mechanisms: (i) secretion of PLA
instead of PLC or (ii) subsequent cleavage of 1,2-DG by bacterial
lipase (36). The latter was regarded as unlikely since CCCS
of Lp6-c was not able to release fatty acids from 1,2-DG (data not
shown). The assumption that L. pneumophila may secrete PLA
was supported by the observation that lysophosphatidylcholine (LPC) was
formed after incubation of surfactant with CCCS of Lp6-c (Fig. 1B).
Generation of LPC after incubation of surfactant with both whole Lp6-c
bacteria and CCCS of Lp6-c could be confirmed by 31P
nuclear magnetic resonance spectroscopy (Flieger et al., submitted).
|
Since we could not find characteristic cleavage products of PLC, we
intended to purify the enzyme as described by Baine, with some
modifications (2) to exclude further hydrolysis of the cleavage products by other enzymes that are concomitantly secreted by
legionellae, such as phosphatases (15, 31) or lipases
(36). Fractions after AEC of CCCS (Lp6-c) were tested for
their ability to hydrolyze p-NPPC. According to Baine
(2), fractions eluted at 0.1 to 0.2 M sodium chloride showed
hydrolysis toward p-NPPC (Fig.
2). Analysis of these fractions by
SDS-PAGE revealed the enrichment of a 54-kDa protein among others (Fig.
3). However, when these fractions were
examined for PLC activity, no 1,2-DG and a minimal amount of released
FFA was found by TLC after incubation with Alveofact (Fig.
4). Release of 1,2-DG could not be
stimulated by the addition of manganese ions, calcium ions, or both; by
the addition of zinc ions, magnesium ions, ferric ions, BSA, and
sorbitol; or by variation of pH (5.5 and 9.5, respectively) (data not
shown).
|
|
|
The hydrolysis of p-NPPC by other enzymes affecting phosphate esters is well established (11a, 34, 35). Therefore, we examined 54-kDa-protein AEC fractions showing hydrolysis of p-NPPC for phosphatase activity. Figure 2 shows that 54-kDa-protein AEC fractions were also able to hydrolyze phosphomonoesters. This reaction could be inhibited by the addition of 10 mM sodium potassium tartrate (data not shown), which is a known inhibitor for acid phosphatase (41). We concluded that hydrolysis of p-NPPC by the 54-kDa AEC fractions was caused by phosphatase activity present in these fractions. The existence of both acid and alkaline phosphatases is known in legionellae (15, 31).
Next, we examined the hydrolysis of 3H-PC by CCCS and by the 54-kDa AEC fraction of Lp6-c as described by Baine (2, 3) at final concentrations of 20 and 18 µg of protein/ml, respectively. The 54-kDa AEC fraction did not show hydrolysis of 3H-PC (0.2% hydrolyzed) in contrast to CCCS of Lp6-c, 12.3% hydrolyzed again suggesting that phosphatase was responsible for the hydrolysis of p-NPPC (11a). Additionally, the phospholipase activity present in the CCCS of L. pneumophila showed a reaction pattern completely different from a well-characterized PLC: in the presence of detergent, PLC from C. perfringens was inhibited from hydrolyzing 3H-PC, whereas destruction of 3H-PC by CCCS of Lp6-c was enhanced (data not shown).
It is known that PLC, PLD, the combined action of PLA1 and PLA2, or the collaboration of PLA and acyltransferase are each able to release tritiated water-soluble components such as 3H-PrC, 3H-choline, and 3H-GPC from 3H-PC, respectively. Since we could demonstrate that Legionella possesses PLA (Fig. 1A and B), two possible mechanisms could be responsible for the appearance of radioactivity in the aqueous phase after incubation of CCCS with 3H-PC followed by lipid extraction. First, tritiated LPC produced by PLA is water soluble and can migrate into the aqueous phase during lipid extraction, but we could demonstrate that LPC, even at higher concentrations, is sufficiently extracted with the chloroform-methanol phase (data not shown). Second, water-soluble GPC may be generated from PC by PLA in case both fatty acids are released from the PLs.
Therefore, we determined the release of water-soluble products from
Alveofact by CCCS of Lp6-c by using ESI-MS. PrC (signals at 184.0 [PrC-H], 205.9 [PrC-Na], and 221.9 [PrC-K]) could be found after
incubation of PLC from C. perfringens with surfactant (data
not shown). After incubation of CCCS of Lp6-c with Alveofact, only GPC
(signals at 258.0 [GPC-H], 279.9 [GPC-Na], and 295.9 [GPC-K]) but
not PrC could be detected (Fig. 5). Since
the concentration of inorganic phosphate within the aqueous phase of
lipid extraction did not increase after incubation of PLs with CCCS of
Lp6-c (data not shown), a possible cleavage of PrC by phosphatases
could be excluded. These results further support the absence of PLC
secretion in Lp6-c. Instead, PLA activity could be detected by
formation of FFA, LPC, and GPC from the PLs. Due to the generation of
GPC by Lp6-c, we assume that both PLA1 and PLA2
are secreted by Lp6-c. However, the presence of a single PLA activity
plus additional acyltransferase activity which can cause transition of
fatty acid chains within the lipid molecule must be taken into account.
|
We can conclude that the previously described phospholipase activity in L. pneumophila (2, 3) may have been misinterpreted as PLC due to the hydrolysis of p-NPPC by Legionella phosphatase and the generation of 3H-GPC (which was formerly suspected to be 3H-PrC) as a water-soluble product released from 3H-PC by PLA.
Finally, we examined the distribution of PLA secretion among different
Legionella species. We could show that, except Lm-ATCC, Lm-CDC, and Ls-ATCC, all species under investigation were able to
secrete PLA activity (Fig. 6). Baine
reported that, with the exception of L. micdadei, all
species showed hydrolysis of 3H-PC (3). This
finding further supports the assumption of misinterpretation of
3H-PC hydrolysis by Legionella phospholipase at
that time.
|
We found that PLA secretion started with the mid-exponential-growth
phase and reached maximal extent with entry into stationary-growth phase. With the exception of La-CDC, Ls-CDC, and Lo-CDC which reached
an OD of about 2 in 24 to 36 h, all other strains achieved an OD
of about 2 in 16 h. A delayed growth in BYE broth was accompanied by delayed PLA secretion (data not shown). A considerable difference in
PLA secretion between Ls-ATCC (strain with unknown passage history,
with no PLA) and Ls-CDC (isolate passaged fewer than three times on
BCYE
agar, with high PLA) could be detected (Fig. 6). A prolonged
passage history of the ATCC strain can be responsible for agar
adaptation and a concomitant loss of PLA as a putative virulence factor
of legionellae.
The discovery of a novel PLA in legionellae leads to speculation about (i) its function in the destruction of lung surfactant and the subsequent induction of acute respiratory distress syndrome during Legionnaires' disease (1, 7, 19, 23, 30, 39; Flieger et al., submitted), (ii) its capacity to elicit inflammation (18, 24), (iii) its influence on signal transduction in host cells (4, 8, 9, 21, 29), (iv) its contribution to uptake and intracellular multiplication (pore formation, inhibition of phagosome-lysosome fusion by induction of phospholipid rearrangement) in amoebae and alveolar macrophages (1, 13, 14, 16, 17, 22, 26, 32, 38), (v) its significance for the escape of bacteria from the phagosome after intracellular replication (6), and (vi) its ability to acquire nutritional substances (11).
Thus, PLA activity within the genus Legionella may contribute to many different steps during pathogenesis. Detailed investigations are now necessary to determine the key mechanisms which are associated with PLA secretion.
| |
ACKNOWLEDGMENTS |
|---|
We acknowledge Hinnak Northoff, Elvira Fehrenbach, Friedrich Goetz, Andreas Peschel, and Markus Koerber for helpful suggestions. We thank Martha Szamel and Wilhelm Stoffel, who helped to promote this investigation by their scientific experiences. We thank Eckhart Schmidt for support with the ESI-MS. We acknowledge Josef Mussotter and Eberhardt Weller for supportive discussions about PL biochemistry. We thank Barry Fields, Christian Lück, and Gotthardt Ruckdeschel for providing Legionella strains.
Antje Flieger was supported by grants of Boehringer-Ingelheim-Pharma-KG (Biberach, Germany), the Boehringer-Ingelheim-Foundation (Mainz, Germany), and the Fortuene Fund (179-1 and 179-2; University Hospital of Tubingen, Tubingen, Germany). Shimei Gong was supported by the Fortuene Fund (305-1 and 305-2; University Hospital of Tubingen, Tubingen, Germany).
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Abteilung für Transfusionsmedizin, Zentrum für Medizinische Forschung des Universitätsklinikums Tübingen, Waldhörnlestr. 22, D-72072 Tübingen, Germany. Phone: 49-7071-2981127. Fax: 49-7071-295142. E-mail: antje.flieger{at}uni-tuebingen.de.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Aronson, J. F., and L. W. Johns. 1977. Injury of lung alveolar cells by lysolecithin. Exp. Mol. Pathol. 27:35-42[CrossRef][Medline]. |
| 2. |
Baine, W. B.
1988.
A phospholipase C from the Dallas 1E strain of Legionella pneumophila serogroup 5: purification and characterization of conditions of optimal activity with an artificial substrate.
J. Gen. Microbiol.
134:489-498 |
| 3. | Baine, W. B. 1985. Cytolytic and phospholipase C activity in Legionella species. J. Gen. Microbiol. 13:1383-1391. |
| 4. | Belyi, Y. F. 1993. Intracellular parasitism of Legionella and signaling in eukaryotic cells. FASEB J. 7:1011-1005[Abstract]. |
| 5. | Bligh, E. G., and W. J. Dyer. 1959. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37:911-917. |
| 6. | Camilli, A., L. G. Tilney, and D. A. Portnoy. 1993. Dual roles of plcA in Listeria monocytogenes pathogenesis. Mol. Microbiol. 8:143-157[Medline]. |
| 7. |
Conlan, J. W.,
A. Williams, and L. A. Ashworth.
1988.
In vivo production of a tissue-destructive protease by Legionella pneumophila in the lungs of experimentally infected guinea pigs.
J. Gen. Microbiol.
134:143-149 |
| 8. |
Coxon, P. Y.,
J. T. Summersgill,
J. A. Ramirez, and R. D. Miller.
1998.
Signal transduction during Legionella pneumophila entry into human monocytes.
Infect. Immun.
66:2905-2913 |
| 9. | Dennis, E. A. 1997. The growing phospholipase A2 superfamily of signal transduction enzymes. Trends Biochem. Sci. 22:1-2[CrossRef][Medline]. |
| 10. | Eibl, H., and W. E. Lands. 1969. A new, sensitive determination of phosphate. Anal. Biochem. 30:51-57[CrossRef][Medline]. |
| 11. | Finnerty, W. R., R. A. Makula, and J. C. Feeley. 1979. Cellular lipids of the Legionnaires' disease bacterium. Ann. Intern. Med. 90:631-634. |
| 11a. | Flieger, A., S. Gong, M. Faigle, and B. Neumeister. Critical evaluation of p-nitrophenylphosphorylcholine (p-NPPC) as artificial substrate for the detection of phospholipase C. Enzyme Microb. Technol., in press. |
| 12. |
Holm, B. A.,
L. Keicher,
M. Y. Liu,
J. Sokolowski, and G. Enhorning.
1991.
Inhibition of pulmonary surfactant function by phospholipases.
J. Appl. Physiol.
71:317-321 |
| 13. |
Horwitz, M. A., and F. R. Maxfield.
1984.
Legionella pneumophila inhibits acidification of its phagosome in human monocytes.
J. Cell Biol.
99:1936-1943 |
| 14. |
Horwitz, M. A.
1983.
The Legionnaires' disease bacterium (Legionella pneumophila) inhibits phagosome-lysosome fusion in human monocytes.
J. Exp. Med.
158:2108-2126 |
| 15. | Kim, M. J., J. H. Rogers, M. C. Hurley, and N. C. Engleberg. 1994. Phosphatase-negative mutants of Legionella pneumophila and their behavior in mammalian cell infection. Microb. Pathog. 17:51-62[CrossRef][Medline]. |
| 16. | Kirby, J. E., and R. R. Isberg. 1998. Legionnaires' disease: the pore macrophage and the legion of terror within. Trends Microbiol. 6:256-258[CrossRef][Medline]. |
| 17. | Kirby, J. E., J. P. Vogel, H. L. Andrews, and R. R. Isberg. 1998. Evidence for pore-forming ability by Legionella pneumophila. Mol. Microbiol. 27:323-336[CrossRef][Medline]. |
| 18. | Kume, N., M. I. Cybulsky, and M. A. Gimbrone, Jr. 1992. Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. J. Clin. Investig. 90:1138-1144. |
| 19. | Kwaik, Y. A. 1998. Fatal attraction of mammalian cells to Legionella pneumophila. Mol. Microbiol. 30:689-695[CrossRef][Medline]. |
| 20. | Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685[CrossRef][Medline]. |
| 21. | Lambeth, J. D. 1997. Receptor-regulated phospholipases and their generation of lipid mediators, which activate protein kinase C, p. 121-170. In J. F. Kuo (ed.), Protein kinase C 1994. Oxford University Press, New York, N.Y. |
| 22. | Lindahl, M., A. R. Hede, and C. Tagesson. 1986. Lysophosphatidylcholine increases airway and capillary permeability in the isolated perfused rat lung. Exp. Lung Res. 11:1-12[Medline]. |
| 23. | Muller, A., J. Hacker, and B. C. Brand. 1996. Evidence for apoptosis of human macrophage-like HL-60 cells by Legionella pneumophila infection. Infect. Immun. 64:4900-4906[Abstract]. |
| 24. | Neumeister, B., A. Kleihauer, V. Rossmann, E. Fehrenbach, M. Faigle, S. Baumbach, M. Eichner, and H. Northoff. 1998. Induction of cytokines and expression of macrophage surface receptors in Mono Mac 6 cells after infection with different Legionella species. APMIS 106:319-333[Medline]. |
| 25. | Neumeister, B., S. Schoniger, M. Faigle, M. Eichner, and K. Dietz. 1997. Multiplication of different Legionella species in Mono Mac 6 cells and in Acanthamoeba castellanii. Appl. Environ. Microbiol. 63:1219-1224[Abstract]. |
| 26. |
Niewoehner, D. E.,
K. Rice,
A. A. Sinha, and D. Wangensteen.
1987.
Injurious effects of lysophosphatidylcholine on barrier properties of alveolar epithelium.
J. Appl. Physiol.
63:1979-1986 |
| 27. | Pasculle, A. W., J. C. Feeley, R. J. Gibson, L. G. Cordes, R. L. Myerowitz, C. M. Patton, G. W. Gorman, C. L. Carmack, J. W. Ezzell, and J. N. Dowling. 1980. Pittsburgh pneumonia agent: direct isolation from human lung tissue. J. Infect. Dis. 141:727-732[Medline]. |
| 28. | Petty, T. L. 1990. Acute respiratory distress syndrome (ARDS). Dis. Mon. 36:1-58[Medline]. |
| 29. | Prokazova, N. V., N. D. Zvezdina, and A. A. Korotaeva. 1998. Effect of lyso-phosphatidylcholine on transmembrane signal transduction. Biochem. Mosc. 63:31-37. |
| 30. | Rice, K. L., P. G. Duane, and D. E. Niewoehner. 1987. Lysophosphatidylcholine augments elastase-induced alveolar epithelial permeability and emphysema in the hamster. Am. Rev. Respir. Dis. 136:941-946[Medline]. |
| 31. | Saha, A. K., J. N. Dowling, K. L. LaMarco, S. Das, A. T. Remaley, N. Olomu, M. T. Pope, and R. H. Glew. 1985. Properties of an acid phosphatase from Legionella micdadei which blocks superoxide anion production by human neutrophils. Arch. Biochem. Biophys. 243:150-160[CrossRef][Medline]. |
| 32. | Segal, G., and H. A. Shuman. 1998. How is the intracellular fate of the Legionella pneumophila phagosome determined? Trends Microbiol. 6:253-255[CrossRef][Medline]. |
| 33. | Shortridge, V. D., A. Lazdunski, and M. L. Vasil. 1992. Osmoprotectants and phosphate regulate expression of phospholipase C in Pseudomonas aeruginosa. Mol. Microbiol. 6:863-871[CrossRef][Medline]. |
| 34. | Sok, D. E., and M. R. Kim. 1992. A spectrophotometric assay of Zn2+-glycerolphosphorylcholine phosphocholine phosphodiesterase using p-nitrophenylphosphorylcholine. Anal. Biochem. 203:201-205[CrossRef][Medline]. |
| 35. | Srivastava, P. N., J. M. Brewer, and R. A. White, Jr. 1982. Hydrolysis of p-nitrophenylphosphorylcholine by alkaline phosphatase and phospholipase C from rabbit sperm-acrosome. Biochem. Biophys. Res. Commun. 108:1120-1125[CrossRef][Medline]. |
| 36. |
Thorpe, T. C., and R. D. Miller.
1981.
Extracellular enzymes of Legionella pneumophila.
Infect. Immun.
33:632-635 |
| 37. |
Touchstone, J. C.,
S. S. Levin,
M. F. Dobbins,
L. Matthews,
P. C. Beers, and S. G. Gabbe.
1983.
(3-sn-Phosphatidyl)cholines (lecithins) in amniotic fluid.
Clin. Chem.
29:1951-1954 |
| 38. | Weltzien, H. U. 1979. Cytolytic and membrane-perturbing properties of lysophosphatidylcholine. Biochim. Biophys. Acta 559:259-287[Medline]. |
| 39. | Winn, W. C., Jr., and R. L. Myerowitz. 1981. The pathology of the Legionella pneumonias. A review of 74 cases and the literature. Hum. Pathol. 12:401-222[Medline]. |
| 40. | Wong, M. C., W. L. Peacock, R. M. McKinney, and K. H. Wong. 1981. Legionella pneumophila: avirulent to virulent conversion through passage in cultured human embryonic lung fibroblasts. Curr. Microbiol. 5:31-34. |
| 41. | Zollner, H. 1993. Handbook of enzyme inhibitors. VCH, Weinheim, Germany. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»